Parameswaran N Hari (Parameswaran Hari)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Topics

Multiple Myeloma

Genome Wide Association

Newly Diagnosed

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Natalie S Callander, Rebecca Silbermann, Jonathan L Kaufman, Kelly N Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi N Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D Anderson, Bhagirathbhai R Dholaria, Nitya Nathwani, Parameswaran N Hari, Nina Shah, Naresh Bumma, Sarah A Holstein, Caitlin Costello, Andrzej J Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Smith Giri, Luciano José Megale Costa, Saad Z Usmani, Paul Gerard Richardson, Peter M Voorhees
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. Blood cancer journal 14 (1) (2024)
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah K Choe, Mark R Litzow, Camille N Abboud, Nebu Koshy, Patrick Joseph Stiff, Benjamin K Tomlinson, Sunil Abhyankar, James M Foran, Parameswaran N Hari, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie J Orozco, Katarzyna Jamieson, Margarida Silverman, Koen van Besien, Michael Schuster, Arjun Datt Law, Karilyn T M Larkin, Neeta Pandit-Taskar, Scott Douglas Rowley, Pashna Munshi, Rachel Cook, Moshe Y Levy, Hillard M Lazarus, Brenda M Sandmaier, John M Pagel, Vijay Reddy, James MacDougall, Kathleen McNamara, Jennifer Spross, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, Avinash Desai, Sergio A Giralt
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Marcelo C Pasquini, Paul K Wallace, Brent R Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy L Geller, Sergio A Giralt, Parameswaran N Hari, Mary M Horowitz, John Koreth, Amrita Y Krishnan, Heather J Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, Theresa Hahn
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Christopher Staffi Buradagunta, Shahram Arsang-Jang, Ben Massat, Bicky Thapa, Victoria Patek, Anita D Souza, Paul Auer, Raul Urrutia, Siegfried Janz, Binod Dhakal, Parameswaran N Hari, Jing Dong
Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance. Leukemia (2023)
Ehsan Malek, Jeries Kort, Leland L Metheny, Pingfu Fu, Parameswaran N Hari, Gen Li, Yvonne A Efebera, Natalie S Callander, Muzaffar H Qazilbash, Sergio A Giralt, Amrita Krishnan, Edward Stadtmauer, Hillard Lazarus
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial. Research square (2023)
Ariel Kleman, Arun K Singavi, Lauren Pommert, Angela Joy Mathison, Parameswaran N Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer Mary Knight, Mithun Vinod Shah, Carolina D Schinke, Robert Thomas Burns, George Francis Steinhardt, Sridhar Rao, Karen-Sue Barker Carlson
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. Blood advances (2023)
Angela Dispenzieri, Amrita Krishnan, Bonnie Arendt, Beth Blackwell, Paul K Wallace, Surendra Dasari, Dan T Vogl, Yvonne A Efebera, Mingwei Fei, Nancy Geller, Sergio A Giralt, Theresa Hahn, Alan Howard, Mindy Kohlhagen, Heather J Landau, Parameswaran N Hari, Marcelo C Pasquini, Muzaffar H Qazilbash, Philip McCarthy, Nina Shah, David H Vesole, Edward Stadtmauer, David L Murray
Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT). Blood cancer journal 12 (2) (2022)
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, Mounzer Agha, Adam David Cohen, Parameswaran N Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C Munshi, Elizabeth O'Donnell, A Keith Stewart, Jordan M Schecter, Jenna D Goldberg, Carolyn C Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej J Jakubowiak, Yi Lin, Sundar Jagannath
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jennifer Mary Knight, Aniko Szabo, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett, Garrett Sauber, Sharon Yim, Bryon Johnson, Parameswaran N Hari, Dina Schneider, Boro Dropulic, Rachel N Cusatis, Steve W Cole, Cecilia J Hillard, Nirav N Shah
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. Communications medicine 2 (2022)
Mark G Frattini, Parameswaran N Hari, Amy Blithe, Dilan Paranagama, Valkal Bhatt, John F Dipersio
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program. Bone marrow transplantation 57 (6) (2022)
Jennifer Mary Knight, Aniko Szabo, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett, Garrett Sauber, Sharon Yim, Bryon Johnson, Parameswaran N Hari, Dina Schneider, Boro Dropulic, Rachel N Cusatis, Steve W Cole, Cecilia J Hillard, Nirav N Shah
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. Communications medicine 2 (1) (2022)
Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P Thrift, Parameswaran N Hari
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study. Blood cancer journal 12 (2) (2022)
Christopher Staffi Buradagunta, Zhuping Garacci, Anita D Souza, Binod Dhakal, Sumana Devata, Siegfried Janz, Aaron P Thrift, Parameswaran N Hari, Melinda Stolley, Jing Dong
Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study. Blood cancer journal 12 (5) (2022)
Meera Mohan, Sneha Nagavally, Binod Dhakal, Sabarinath Venniyil Radhakrishnan, Saurabh Chhabra, Anita D'Souza, Parameswaran N Hari
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma. Blood advances 6 (8) (2022)
Bicky Thapa, Gulrayz Ahmed, Meera Mohan, Volodymyr Shponka, Parameswaran N Hari
Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation. Case reports in hematology 2021 (2021)
Susan Bal, Ehsan Malek, Ankit Kansagra, Saad Z Usmani, Ravi Vij, Kelly N Godby, Robert F Cornell, Yubin Kang, Elvira Umyarova, Smith Giri, Saurabh Chhabra, Michaela Liedtke, Natalie S Callander, Parameswaran N Hari, Shaji K Kumar, Luciano J Costa
Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies. Leukemia (2021)
Luciano José Megale Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai R Dholaria, Timothy Martin Schmidt, Kelly N Godby, Rebecca W Silbermann, Binod Dhakal, Susan Bal, Smith Giri, Anita D Souza, Aric C Hall, Pamela Hardwick, James Omel, Robert Frank Cornell, Parameswaran N Hari, Natalie S Callander
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2021)
Binod Dhakal, Sameem Abedin, Timothy Fenske, Saurabh Chhabra, Nathan Ledeboer, Parameswaran N Hari, Mehdi Hamadani
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy. Blood 138 (14) (2021)